D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
CALL
Bunge Global
BG
$23.6B
| $205K | ﹤0.01% |
5,000
| – | – |
|
3552
Lifecore Biomedical
LFCR
$162M
| $205K | ﹤0.01% |
23,607
-46,833
| -66% | -$487K |
|
3553
CoStar Group
CSGP
$11.3B
| $204K | ﹤0.01% |
3,480
-141,190
| -98% | -$9.2M |
|
3554
CALL
FTI Consulting
FCN
$4.82B
| $204K | ﹤0.01% |
+1,700
| New | +$200K |
|
3555
PUT
Tilray
TLRY
$479M
| $204K | ﹤0.01% |
2,970
-3,800
| -56% | -$531K |
|
|
NEX
3556
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $204K | ﹤0.01% |
174,219
-312,500
| -64% | -$1.37M |
|
|
PRTY
3557
DELISTED
Party City Holdco Inc.
PRTY
| $204K | ﹤0.01% |
445,687
+311,622
| +232% | +$640K |
|
|
GES
3558
PUT
DELISTED
Guess Inc
GES
| $203K | ﹤0.01% |
+30,000
| New | +$522K |
|
|
OPTN
3559
DELISTED
OptiNose
OPTN
| $201K | ﹤0.01% |
2,991
+909
| +44% | +$91.6K |
|
3560
Target Hospitality
TH
$1.61B
| $201K | ﹤0.01% |
100,697
+43,028
| +75% | +$181K |
|
|
ETRN
3561
PUT
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $201K | ﹤0.01% |
40,000
| – | – |
|
3562
Standex International
SXI
$3.68B
| $200K | ﹤0.01% |
4,089
-1,966
| -32% | -$129K |
|
|
CTRA
3563
CALL
DELISTED
Coterra Energy
CTRA
| $199K | ﹤0.01% |
11,600
| – | – |
|
3564
Ocular Therapeutix
OCUL
$1.86B
| $199K | ﹤0.01% |
+40,172
| New | +$198K |
|
|
HEXO
3565
DELISTED
HEXO Corp. Common Shares
HEXO
| $199K | ﹤0.01% |
4,348
+1,700
| +64% | +$115K |
|
3566
PUT
Methanex
MEOH
$4.32B
| $197K | ﹤0.01% |
16,200
-7,300
| -31% | -$210K |
|
|
MRO
3567
PUT
DELISTED
Marathon Oil Corporation
MRO
| $197K | ﹤0.01% |
+60,000
| New | +$553K |
|
3568
Genesco
GCO
$396M
| $196K | ﹤0.01% |
14,703
-65,892
| -82% | -$2.22M |
|
3569
Motorcar Parts of America
MPAA
$261M
| $196K | ﹤0.01% |
15,584
-24,252
| -61% | -$444K |
|
|
DS
3570
DELISTED
Drive Shack Inc.
DS
| $196K | ﹤0.01% |
128,789
+75,299
| +141% | +$224K |
|
3571
Dave & Buster's
PLAY
$343M
| $193K | ﹤0.01% |
+14,778
| New | +$506K |
|
3572
VSE Corp
VSEC
$5.48B
| $193K | ﹤0.01% |
11,755
+114
| +1% | +$3.25K |
|
|
TEN
3573
Tsakos Energy Navigation Ltd
TEN
$1.19B
| $192K | ﹤0.01% |
11,758
-6,770
| -37% | -$104K |
|
3574
Anavex Life Sciences
AVXL
$222M
| $191K | ﹤0.01% |
60,758
-10,792
| -15% | -$37.6K |
|
|
FONR
3575
DELISTED
Fonar
FONR
| $191K | ﹤0.01% |
13,078
+1,721
| +15% | +$31.8K |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.